{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:47:07Z","timestamp":1785934027169,"version":"3.56.0"},"reference-count":21,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Epstein-Barr virus-associated smooth muscle tumours (EBV-SMTs) are rare neoplasms typically affecting immunosuppressed individuals such as organ transplant recipients. This case follows a woman in her 30s who presented with multi-organ masses 5 years after a kidney transplant. While initial suspicion focused on common post-transplant infections or malignancy, a liver biopsy revealed a smooth muscle neoplasm positive for EBV by EBV-encoded RNA in-situ hybridisation, consistent with EBV-SMT. Managing EBV-SMT is challenging as no standardised treatment regimens exist. When reducing immunosuppression\u2014the conventional first-line approach\u2014failed, a multidisciplinary team opted for a non-standard regimen including Valganciclovir and Pazopanib, which is not a recognised therapy for this condition. The patient achieved a partial metabolic response and maintained stable disease at a 2\u2009year follow-up. This case emphasises the importance of considering this differential when encountering spindle cell neoplasms in an immunosuppressed setting while highlighting the necessity of establishing standardised treatment guidelines for this rare disease.<\/jats:p>","DOI":"10.1136\/bcr-2025-265938","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:55:12Z","timestamp":1785930912000},"page":"e265938","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Epstein-Barr virus-associated smooth muscle tumour in an immunosuppressed patient: a rare clinical scenario"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-999X","authenticated-orcid":false,"given":"Hena","family":"Khandakar","sequence":"first","affiliation":[{"name":"Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Rastogi","sequence":"additional","affiliation":[{"name":"Medical Oncology, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamini","family":"Dharmashaktu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-4895","authenticated-orcid":false,"given":"Rajni","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2026080504550523000_19.8.e265938.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"key":"2026080504550523000_19.8.e265938.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037505","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017","volume":"10","author":"Khan","year":"2020","journal-title":"BMJ Open"},{"key":"2026080504550523000_19.8.e265938.3","first-page":"1362","article-title":"Malignant tumours following immunosuppressive therapy","volume":"103","author":"Pritzker","year":"1970","journal-title":"Can Med Assoc J"},{"key":"2026080504550523000_19.8.e265938.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501053320104"},{"key":"2026080504550523000_19.8.e265938.5","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0120-RS"},{"key":"2026080504550523000_19.8.e265938.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw160"},{"key":"2026080504550523000_19.8.e265938.7","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000178088.69394.7b"},{"key":"2026080504550523000_19.8.e265938.8","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199901)57:1<36::AID-JMV6>3.0.CO;2-1"},{"key":"2026080504550523000_19.8.e265938.9","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/659603"},{"key":"2026080504550523000_19.8.e265938.10","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1600-6143.2012.04011.x","article-title":"Molecular and clinicopathological analysis of Epstein-Barr virus-associated posttransplant smooth muscle tumors","volume":"12","author":"Jonigk","year":"2012","journal-title":"Am J Transplant"},{"key":"2026080504550523000_19.8.e265938.11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2979"},{"key":"2026080504550523000_19.8.e265938.12","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/859407","article-title":"EBV-Associated Smooth Muscle Neoplasms: Solid Tumors Arising in the Presence of Immunosuppression and Autoimmune Diseases","volume":"2008","author":"Moore Dalal","year":"2008","journal-title":"Sarcoma"},{"key":"2026080504550523000_19.8.e265938.13","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13010","article-title":"Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature","volume":"21","author":"Stubbins","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2026080504550523000_19.8.e265938.14","doi-asserted-by":"crossref","first-page":"100127","DOI":"10.1016\/j.modpat.2023.100127","article-title":"Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus-Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma","volume":"36","author":"Wah","year":"2023","journal-title":"Mod Pathol"},{"key":"2026080504550523000_19.8.e265938.15","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000782","article-title":"Hepatic Epstein-Barr Virus-Associated Smooth Muscle Tumor in a Heart and Liver Transplant Recipient","volume":"9","author":"Johnson","year":"2022","journal-title":"ACG Case Rep J"},{"key":"2026080504550523000_19.8.e265938.16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1159\/000530383","article-title":"Clinical Course of a Rare Epstein-Barr Virus-Associated Smooth Muscle Tumor and Its Genomic Analysis","volume":"16","author":"Miyahara","year":"2023","journal-title":"Case Rep Oncol"},{"key":"2026080504550523000_19.8.e265938.17","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12860","article-title":"A rare case of Epstein-Barr virus-associated hepatosplenic smooth muscle tumors after kidney transplantation","volume":"20","author":"Pircher","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2026080504550523000_19.8.e265938.18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5306\/wjco.v13.i6.540","article-title":"Epstein-Barr virus-associated smooth muscle tumors in immunocompromised patients: Six case reports","volume":"13","author":"Khan","year":"2022","journal-title":"WJCO"},{"key":"2026080504550523000_19.8.e265938.19","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.21037\/jgo-21-700","article-title":"Concurrent Epstein Barr virus-associated smooth muscle tumor and myeloid sarcoma of the liver and acute myeloid leukemia in a patient post kidney transplant: a case report and review of the literature","volume":"13","author":"Wang","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"2026080504550523000_19.8.e265938.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02054.x"},{"key":"2026080504550523000_19.8.e265938.21","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1200\/JCO.2019.37.15_suppl.7551","article-title":"A phase Ib\/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas","volume":"37","author":"Porcu","year":"2019","journal-title":"JCO"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-265938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:55:14Z","timestamp":1785930914000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-265938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bcr-2025-265938"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-265938","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}